Effects of autoimmunity on recovery of function in adult rats following spinal cord injury

Brain, Behavior, and Immunity

Volumn 22, Issue 8, 2008, Pages 1217-1230

  Lü, He Zuo ^a   Xu, Liang ^a   Zou, Jian ^a   Wang, Yan Xia ^a   Ma, Zheng Wen ^a   Xu, Xiao Ming ^a,b   Lu, Pei Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Myelin basic protein; Neuroprotection; Passive immunization; Spinal cord injury; Thymectomy

Indexed keywords

CONCANAVALIN A; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BEHAVIOR; CD4+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; FEMALE; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MALE; NERVE CELL; NEUROPROTECTION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PATHOGENESIS; POSTTRAUMATIC COMPLICATION; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPINAL CORD INJURY; T LYMPHOCYTE; THYMECTOMY; TISSUE HOMOGENATE; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; AUTOIMMUNITY; CELL SURVIVAL; CYTOPROTECTION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNIZATION, PASSIVE; INFLAMMATION; LYMPHOCYTE ACTIVATION; MICROSCOPY, ELECTRON; MOTOR ACTIVITY; MOTOR NEURONS; MYELIN BASIC PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL CORD INJURIES; STAINING AND LABELING; T-LYMPHOCYTES; THORACIC VERTEBRAE; THYMECTOMY; TIME FACTORS;

EID: 52949150051     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.06.006     Document Type: Article

References (60)

1. Ankeny D.P., and Popovich P.G. Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury. Eur. J. Neurosci. 25 (2007) 2053-2064
2. Avidan H., Kipnis J., Butovsky O., Caspi R.R., and Schwartz M. Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells. Eur. J. Immunol. 34 (2004) 3434-3445
3. Barouch R., and Schwartz M. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 16 (2002) 1304-1306
4. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma. 12 (1995) 1-21
5. Basso D.M., Beattie M.S., Bresnahan J.C., Anderson D.K., Faden A.I., Gruner J.A., Holford T.R., Hsu C.Y., Noble L.J., Nockels R., Perot P.L., Salzman S.K., and Young W. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter animal spinal cord injury study. J. Neurotrauma. 13 (1996) 343-359
6. Battaglia M., Gregori S., Bacchetta R., and Roncarolo M.G. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18 (2006) 120-127
7. Becher B., Bechmann I., and Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84 (2006) 532-543
8. Beignon A.S., Briand J.P., Rappuoli R., Muller S., and Partidos C.D. The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin. Infect. Immun. 70 (2002) 3012-3019
9. Bretscher P., and Cohn M. A theory of self-nonself discrimination. Science 169 (1970) 1042-1049
10. Butovsky O., Bukshpan S., Kunis G., Jung S., and Schwartz M. Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers. Mol. Cell Neurosci. 35 (2007) 490-500
11. Cao Q., Zhang Y.P., Iannotti C., DeVries W.H., Xu X.M., Shields C.B., and Whittemore S.R. Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol. 191 Suppl. 1 (2005) S3-S16
12. Choi E.W., Shin I.S., Bhang D.H., Lee D.H., Bae B.K., Kang M.S., Kim D.Y., Hwang C.Y., Lee C.W., and Youn H.Y. Hormonal change and cytokine mRNA expression in peripheral blood mononuclear cells during the development of canine autoimmune thyroiditis. Clin. Exp. Immunol. 146 (2006) 101-108
13. Clayton J.P., Gammon G.M., Ando D.G., Kono D.H., Hood L., and Sercarz E.E. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 169 (1989) 1681-1691
14. Dahl D., Crosby C.J., and Bignami A. Intermediate filament proteins immunologically related to desmin in astrocytes: a study of chicken spinal cord by two-dimensional gel electrophoresis and immunoblotting. Neurochem. Res. 14 (1989) 1013-1016
15. Esquifino A.I., Cano P., Jimenez-Ortega V., Fernandez-Mateos M.P., and Cardinali D.P. Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J. Neuroinflamm. 4 (2007) 6
16. Farooque M., Suo Z., Arnold P.M., Wulser M.J., Chou C.T., Vancura R.W., Fowler S., and Festoff B.W. Gender-related differences in recovery of locomotor function after spinal cord injury in mice. Spinal cord 44 (2006) 182-187
17. Gauss C., Kalkum M., Lowe M., Lehrach H., and Klose J. Analysis of the mouse proteome. (I) Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis 20 (1999) 575-600
18. Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L., and Schwartz M. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 108 (2001) 591-599
19. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20 (2000) 6421-6430
20. Hauben E., Ibarra A., Mizrahi T., Barouch R., Agranov E., and Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc. Natl. Acad. Sci. USA 98 (2001) 15173-15178
21. Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355 (2000) 286-287
22. Hauben E., Roncarolo M.G., Nevo U., and Schwartz M. Beneficial autoimmunity in Type 1 diabetes mellitus. Trends Immunol. 26 (2005) 248-253
23. Hauben E., and Schwartz M. Therapeutic vaccination for spinal cord injury: helping the body to cure itself. Trends Pharmacol. Sci. 24 (2003) 7-12
24. Heaton M.B., Swanson D.J., and Paiva M. Neurotrophic activity in embryonic chick brain: early appearance and differential regional distribution. Dev. Neurosci. 15 (1993) 1-9
25. Hendrix S., and Nitsch R. The role of T helper cells in neuroprotection and regeneration. J. Neuroimmunol. 184 (2007) 100-112
26. Hickey W.F., Hsu B.L., and Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28 (1991) 254-260
27. Jameson S.C., Hogquist K.A., and Bevan M.J. Positive selection of thymocytes. Annu. Rev. Immunol. 13 (1995) 93-126
28. Jones T.B., Ankeny D.P., Guan Z., McGaughy V., Fisher L.C., Basso D.M., and Popovich P.G. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J. Neurosci. 24 (2004) 3752-3761
29. Jones T.B., Basso D.M., Sodhi A., Pan J.Z., Hart R.P., MacCallum R.C., Lee S., Whitacre C.C., and Popovich P.G. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neurosci. 22 (2002) 2690-2700
30. Jones T.B., Hart R.P., and Popovich P.G. Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J. Neurosci. 25 (2005) 6576-6583
31. Jones T.B., McDaniel E.E., and Popovich P.G. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11 (2005) 1223-1236
32. Kim G., Kohyama K., Tanuma N., Arimito H., and Matsumoto Y. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE. J. Immunol. 161 (1998) 6993-6998
33. Kipnis J., Cardon M., Strous R.D., and Schwartz M. Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia?. Trends Mol. Med. 12 (2006) 107-112
34. Kipnis J., Mizrahi T., Yoles E., Ben-Nun A., and Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 130 (2002) 78-85
35. Kipnis J., Yoles E., Schori H., Hauben E., Shaked I., and Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci. 21 (2001) 4564-4571
36. Lane T.E., Liu M.T., Chen B.P., Asensio V.C., Samawi R.M., Paoletti A.D., Campbell I.L., Kunkel S.L., Fox H.S., and Buchmeier M.J. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 74 (2000) 1415-1424
37. Liu N., Han S., Lu P.H., and Xu X.M. Upregulation of annexins I, II, and V after traumatic spinal cord injury in adult rats. J. Neurosci. Res. 77 (2004) 391-401
38. Liu N.K., Zhang Y.P., Titsworth W.L., Jiang X., Han S., Lu P.H., Shields C.B., and Xu X.M. A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann. Neurol. 59 (2006) 606-619
39. McQualter J.L., and Bernard C.C. Multiple sclerosis: a battle between destruction and repair. J. Neurochem. 100 (2007) 295-306
40. Michel R.P., and Cruz-Orive L.M. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J. Microsc. 150 (1988) 117-136
41. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., and Schwartz M. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun. 15 (2000) 331-345
42. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5 (1999) 49-55
43. Moalem G., Yoles E., Leibowitz-Amit R., Muller-Gilor S., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells retard the loss of function in injured rat optic nerves. J. Neuroimmunol. 106 (2000) 189-197
44. Morley B.J., and Murphy R. Effects of neonatal thymectomy on the densities of nicotinic cholinergic receptors in skeletal muscle and brain. Exp. Neurol. 120 (1993) 277-282
45. Myint A.M., Leonard B.E., Steinbusch H.W., and Kim Y.K. Th1, Th2, and Th3 cytokine alterations in major depression. J. Affect Disord. 88 (2005) 167-173
46. Oorschot D.E. Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog. Neurobiol. 44 (1994) 233-247
47. Popovich P.G., and Jones T.B. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24 (2003) 13-17
48. Popovich P.G., Stokes B.T., and Whitacre C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 45 (1996) 349-363
49. Schori H., Robenshtok E., Schwartz M., and Hourvitz A. Post-intoxication vaccination for protection of neurons against the toxicity of nerve agents. Toxicol. Sci. 87 (2005) 163-168
50. Schwartz M. Macrophages and microglia in central nervous system injury: are they helpful or harmful?. J. Cereb. Blood Flow Metab. 23 (2003) 385-394
51. Schwartz M., and Kipnis J. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol. Med. 7 (2001) 252-258
52. Schwartz M., and Kipnis J. A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis. Trends Pharmacol. Sci. 25 (2004) 407-412
53. Schwartz M., and Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J. Neurol. Sci. 233 (2005) 163-166
54. Schwartz M., and Kipnis J. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells. Ann. NY Acad. Sci. 1051 (2005) 701-708
55. Sedgwick J.D. Immune surveillance and autoantigen recognition in the central nervous system. Aust. NZ J. Med. 25 (1995) 784-792
56. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.M., and Jones K.J. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J. Neurosci. 19 (1999) RC7
57. Shaked I., Tchoresh D., Gersner R., Meiri G., Mordechai S., Xiao X., Hart R.P., and Schwartz M. Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J. Neurochem. 92 (2005) 997-1009
58. Teng Y.D., Mocchetti I., and Wrathall J.R. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur. J. Neurosci. 10 (1998) 798-802
59. Turrini P., Tirassa P., Vigneti E., and Aloe L. A role of the thymus and thymosin-alpha1 in brain NGF levels and NGF receptor expression. J. Neuroimmunol. 82 (1998) 64-72
60. Wucherpfennig K.W. Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. Clin. Immunol. Immunopathol. 72 (1994) 293-306